Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 72 (TMEM72) is a four-transmembrane domain, integral membrane protein of approximately 37 kDa, predominantly localized to the plasma membrane with some presence in early endosomes[1][2][3]. TMEM72 is primarily expressed in the kidney[1][7] and plays an essential role in membrane protein folding, assembly, and trafficking—specifically, in COPII-mediated ER-to-membrane transport[1][2][3][5]. The protein's C-terminal region (particularly residues 132–144) is critical for proper trafficking, which is similarly reflected in its role during normal kidney development and maintenance of membrane integrity[1][2][5]. TMEM72 expression is downregulated in clear cell renal cell carcinoma (ccRCC), and dysfunction may contribute to renal tumorigenesis and chronic kidney disease[3][5][12]. While TMEM72 is functionally uncharacterized in many respects and is not currently established as a therapeutic target, its characteristics suggest it acts as a membrane scaffold or organizer rather than a classical druggable receptor, enzyme, or transporter[1][5][6]. The gene encoding TMEM72 is located on chromosome 10 (C10orf127), and a mouse homolog (Tmem72) shares similar characteristics[4][7]. There is no strong evidence for TMEM72 acting as a direct receptor, transporter, or enzyme, nor are there current drugs or recognized biomarkers targeting it[1][6][7][10]. It may have emerging significance in renal cancer biology, but mechanistic and clinical data are limited at this time[5][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 72 (TMEM72).